» Articles » PMID: 21084727

A STAT3-mediated Metabolic Switch is Involved in Tumour Transformation and STAT3 Addiction

Abstract

The pro-oncogenic transcription factor STAT3 is constitutively activated in a wide variety of tumours that often become addicted to its activity, but no unifying view of a core function determining this widespread STAT3-dependence has yet emerged. We show here that constitutively active STAT3 acts as a master regulator of cell metabolism, inducing aerobic glycolysis and down-regulating mitochondrial activity both in primary fibroblasts and in STAT3-dependent tumour cell lines. As a result, cells are protected from apoptosis and senescence while becoming highly sensitive to glucose deprivation. We show that enhanced glycolysis is dependent on HIF-1α up-regulation, while reduced mitochondrial activity is HIF-1α-independent and likely caused by STAT3-mediated down-regulation of mitochondrial proteins. The induction of aerobic glycolysis is an important component of STAT3 pro-oncogenic activities, since inhibition of STAT3 tyrosine phosphorylation in the tumour cell lines down-regulates glycolysis prior to leading to growth arrest and cell death, both in vitro and in vivo. We propose that this novel, central metabolic role is at the core of the addiction for STAT3 shown by so many biologically different tumours.

Citing Articles

Machine Perfusion as a Strategy to Decrease Ischemia-Reperfusion Injury and Lower Cancer Recurrence Following Liver Transplantation.

Garcia K, Hussein A, Satish S, Wehrle C, Karakaya O, Panconesi R Cancers (Basel). 2024; 16(23).

PMID: 39682147 PMC: 11639801. DOI: 10.3390/cancers16233959.


Eye on the horizon: The metabolic landscape of the RPE in aging and disease.

Hansman D, Du J, Casson R, Peet D Prog Retin Eye Res. 2024; 104:101306.

PMID: 39433211 PMC: 11833275. DOI: 10.1016/j.preteyeres.2024.101306.


From immune equilibrium to tumor ecodynamics.

Chen X Front Oncol. 2024; 14:1335533.

PMID: 38807760 PMC: 11131381. DOI: 10.3389/fonc.2024.1335533.


Metabolic Enzymes in Viral Infection and Host Innate Immunity.

Qin C, Xie T, Yeh W, Savas A, Feng P Viruses. 2024; 16(1).

PMID: 38257735 PMC: 10820379. DOI: 10.3390/v16010035.


Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.

Hu Y, Dong Z, Liu K J Exp Clin Cancer Res. 2024; 43(1):23.

PMID: 38245798 PMC: 10799433. DOI: 10.1186/s13046-024-02949-5.


References
1.
Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

2.
Bromberg J, Horvath C, Besser D, Lathem W, Darnell Jr J . Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol. 1998; 18(5):2553-8. PMC: 110635. DOI: 10.1128/MCB.18.5.2553. View

3.
Korshunov S, Skulachev V, Starkov A . High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 1997; 416(1):15-8. DOI: 10.1016/s0014-5793(97)01159-9. View

4.
Rizzuto R, Pozzan T . Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev. 2005; 86(1):369-408. DOI: 10.1152/physrev.00004.2005. View

5.
Chiarle R, Simmons W, Cai H, Dhall G, Zamo A, Raz R . Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med. 2005; 11(6):623-9. DOI: 10.1038/nm1249. View